Medicare Enrolled
Dr. Charles Harring, MD, FACC
Cardiovascular Disease · Delray Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Harring from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harring? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Harring
Dr. Charles Harring is a cardiovascular disease in Delray Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Harring performed 11,347 Medicare services across 5,391 unique beneficiaries.
Between the years covered by Open Payments, Dr. Harring received a total of $18,287 from 61 pharmaceutical and/or device companies across 851 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Harring is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 6% volume in FL$ $18,287 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,347
Medicare services
Top 6% in FL for cardiovascular disease
5,391
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~567 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,599 | $104 | $170 |
| Remote patient monitoring management, 20 min/month | 1,060 | $40 | $80 |
| EKG interpretation and report | 898 | $6 | $10 |
| Remote patient monitoring device, 30 days | 842 | $40 | $95 |
| Hospital follow-up visit, high complexity | 779 | $99 | $164 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 657 | $30 | $55 |
| Electrocardiogram (EKG), 12-lead | 652 | $12 | $27 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 605 | $32 | $66 |
| Office visit, established patient (20-29 min) | 576 | $73 | $118 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 487 | $22 | $44 |
| Initial hospital admission, high complexity | 438 | $143 | $320 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 378 | $90 | $177 |
| Injection, dipyridamole, per 10 mg | 348 | $3 | $48 |
| Echocardiogram, transthoracic | 286 | $158 | $321 |
| Hospital follow-up visit, moderate complexity | 246 | $66 | $115 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 195 | $50 | $110 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 189 | $356 | $736 |
| Remote pacemaker/defibrillator monitoring, 90 days | 183 | $18 | $40 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 172 | $21 | $45 |
| Remote pacemaker monitoring, 90 days | 125 | $24 | $50 |
| New patient office visit (45-59 min) | 103 | $134 | $260 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 60 | $29 | $61 |
| Ultrasound of both sides of head and neck blood flow | 60 | $155 | $310 |
| Regadenoson injection (Lexiscan) for heart stress test | 56 | $27 | $89 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 46 | $21 | $43 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 46 | $668 | $1,083 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 46 | $152 | $303 |
| Insertion of heart rhythm monitor under skin | 36 | $3,531 | $7,799 |
| Office visit, established patient, complex (40-54 min) | 26 | $148 | $229 |
| Office visit, established patient (10-19 min) | 22 | $37 | $72 |
| Emergency department visit, high complexity | 20 | $149 | $282 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $86 | $172 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $14 | $28 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $2 | $5 |
| Removal of heart rhythm monitor from under the skin | 15 | $76 | $222 |
| Initial hospital admission, moderate complexity | 15 | $109 | $219 |
| Ultrasound of heart, follow-up | 12 | $20 | $153 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 12 | $15 | $29 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.1% high complexity
8.2% medium
85.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,287
Total received (2018-2024)
Avg $2,612/year across 7 years
Top 15% in FL for cardiovascular disease
61
Companies
851
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,287 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,465
2023$3,091
2022$3,292
2021$2,873
2020$1,615
2019$1,996
2018$2,956
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$2,411
Actelion Pharmaceuticals US, Inc.
$1,903
Janssen Pharmaceuticals, Inc
$1,266
AstraZeneca Pharmaceuticals LP
$1,259
Amgen Inc.
$1,244
Amarin Pharma Inc.
$862
PFIZER INC.
$737
Novartis Pharmaceuticals Corporation
$609
CVRx, Inc.
$584
E.R. Squibb & Sons, L.L.C.
$583
Merck Sharp & Dohme LLC
$516
Medtronic Vascular, Inc.
$508
Boehringer Ingelheim Pharmaceuticals, Inc.
$482
ABIOMED
$444
BIOTRONIK INC.
$443
Boston Scientific Corporation
$308
HeartFlow, Inc.
$296
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$291
SANOFI-AVENTIS U.S. LLC
$282
Lundbeck LLC
$268
Impulse Dynamics (USA) Inc.
$257
Kowa Pharmaceuticals America, Inc.
$225
Kestra Medical Technology Services, Inc.
$181
Alnylam Pharmaceuticals Inc.
$179
Medtronic, Inc.
$158
Gilead Sciences, Inc.
$133
United Therapeutics Corporation
$125
Bolton Medical Inc
$99
Philips Electronics North America Corporation
$99
Regeneron Healthcare Solutions, Inc.
$98
Acutus Medical, Inc.
$88
CARDIVA MEDICAL, INC.
$85
Lexicon Pharmaceuticals, Inc.
$85
Bayer HealthCare Pharmaceuticals Inc.
$85
Kiniksa Pharmaceuticals, Ltd.
$83
Kiniksa Pharmaceuticals International, plc
$80
Chiesi USA, Inc.
$79
Merck Sharp & Dohme Corporation
$70
Akcea Therapeutics, Inc.
$68
Esperion Therapeutics, Inc.
$64
AGEPHA Pharma FZ LLC
$60
Becton, Dickinson and Company
$60
ARBOR PHARMACEUTICALS, INC.
$59
Tactile Systems Technology Inc
$52
Braemar Manufacturing, LLC
$49
GE HEALTHCARE
$44
BOSTON SCIENTIFIC CORPORATION
$38
Novo Nordisk Inc
$34
Inari Medical, Inc.
$29
CHIESI USA, INC.
$27
Shockwave Medical, Inc
$27
AtriCure, Inc.
$27
Vital Connect, Inc
$24
Bayer Healthcare Pharmaceuticals Inc.
$21
VivaQuant Inc, dba Rhythm Express
$18
Cardinal Health 200, LLC
$16
Allergan Inc.
$15
ZOLL Circulation Inc
$14
HEARTFLOW, INC.
$14
ARALEZ PHARMACEUTICALS US INC.
$13
Coala Life Inc
$10
Top 3 companies account for 30.5% of total payments
Associated products mentioned in payments ›
(6554) Periph Vasc Undiv · (7999) SRC Undivided · AMPLATZER AMULET · AVEIR · Acticor 7 VR-T DX · Advisor Catheter · Arcalyst · Assure WCD · Assurity Pacemaker · BELSOMRA · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CLEVIPREX · CLEVIPREX 25MG/50ML · CONFIRM RX · Cardiac Monitoring Suite · CardioMEMS HF System · CareLink · ClosureFast · Coala Heart Monitor · Cobalt · Confirm Rx · Connectivity and Remote care · Corlanor · ELIQUIS · ENSITE · ENSITE PRECISION · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · EnSite Precision Cardiac Mapping System · EnSite X · FARXIGA · FFRct · FLOWTRIEVER CATHETER · Flexitouch Plus · General - Therapies · INVOKANA · Impella · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LIVALO · LODOCO · LifeVest · Livalo · MERLIN@HOME · MICRA · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · MitraClip System · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · Optimizer Smart System · Ozempic · PERCLOSE PROSTYLE · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM · Repatha · Reveal LINQ · Rhythm Express · S · SENSOR ENABLED · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SensiTherm (ICE) · TACTICATH ABLATION CATHETER · TEGSEDI · TYVASO · TherOx DS2 Console · Tryton Side Branch Stent · UPTRAVI · VENASEAL · VERQUVO · VITALPATCH RTM · VYNDAMAX · VYNDAQEL · Vascepa · Vascular Lithotripsy · VenaSeal · Venclose Maven Catheter · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $161 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
226
Per 100K population
15.0
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Harring is a clinical cardiology specialist, with above-average Medicare volume (top 6% in FL), and high industry engagement (low-engagement, top 15%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Harring experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Harring performed 1,599 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Harring receive payments from pharmaceutical companies?
Yes. Dr. Harring received a total of $18,287 from 61 companies across 851 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harring's costs compare to other cardiovascular diseases in Delray Beach?
Dr. Harring's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harring) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Delray Beach
Browse cardiovascular diseases in Delray Beach ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc..
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology